253 related articles for article (PubMed ID: 11856743)
1. Activation of the c-Jun N-terminal kinase (JNK) signaling pathway is essential during PBOX-6-induced apoptosis in chronic myelogenous leukemia (CML) cells.
Mc Gee MM; Campiani G; Ramunno A; Nacci V; Lawler M; Williams DC; Zisterer DM
J Biol Chem; 2002 May; 277(21):18383-9. PubMed ID: 11856743
[TBL] [Abstract][Full Text] [Related]
2. Selective induction of apoptosis by the pyrrolo-1,5-benzoxazepine 7-[[dimethylcarbamoyl]oxy]-6-(2-naphthyl)pyrrolo-[2,1-d] (1,5)-benzoxazepine (PBOX-6) in Leukemia cells occurs via the c-Jun NH2-terminal kinase-dependent phosphorylation and inactivation of Bcl-2 and Bcl-XL.
Mc Gee MM; Greene LM; Ledwidge S; Campiani G; Nacci V; Lawler M; Williams DC; Zisterer DM
J Pharmacol Exp Ther; 2004 Sep; 310(3):1084-95. PubMed ID: 15143129
[TBL] [Abstract][Full Text] [Related]
3. Pyrrolo-1,5-benzoxazepines induce apoptosis in chronic myelogenous leukemia (CML) cells by bypassing the apoptotic suppressor bcr-abl.
Mc Gee MM; Campiani G; Ramunno A; Fattorusso C; Nacci V; Lawler M; Williams DC; Zisterer DM
J Pharmacol Exp Ther; 2001 Jan; 296(1):31-40. PubMed ID: 11123359
[TBL] [Abstract][Full Text] [Related]
4. Pyrrolo-1,5-benzoxazepines: a new class of apoptotic agents.
Zisterer DM; McGee MM; Campiani G; Ramunno A; Fattorusso C; Nacci V; Lawler M; Williams DC
Biochem Soc Trans; 2001 Nov; 29(Pt 6):704-6. PubMed ID: 11709059
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic mitogen-activated protein/extracellular signal-regulated kinase kinase/mitogen-activated protein kinase inhibitors interact synergistically with STI571 to induce apoptosis in Bcr/Abl-expressing human leukemia cells.
Yu C; Krystal G; Varticovksi L; McKinstry R; Rahmani M; Dent P; Grant S
Cancer Res; 2002 Jan; 62(1):188-99. PubMed ID: 11782377
[TBL] [Abstract][Full Text] [Related]
6. Ceramide promotes apoptosis in chronic myelogenous leukemia-derived K562 cells by a mechanism involving caspase-8 and JNK.
Nica AF; Tsao CC; Watt JC; Jiffar T; Kurinna S; Jurasz P; Konopleva M; Andreeff M; Radomski MW; Ruvolo PP
Cell Cycle; 2008 Nov; 7(21):3362-70. PubMed ID: 18948750
[TBL] [Abstract][Full Text] [Related]
7. Selective pyrrolo-pyrimidine inhibitors reveal a necessary role for Src family kinases in Bcr-Abl signal transduction and oncogenesis.
Wilson MB; Schreiner SJ; Choi HJ; Kamens J; Smithgall TE
Oncogene; 2002 Nov; 21(53):8075-88. PubMed ID: 12444544
[TBL] [Abstract][Full Text] [Related]
8. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells.
Yu W; Liao QY; Hantash FM; Sanders BG; Kline K
Cancer Res; 2001 Sep; 61(17):6569-76. PubMed ID: 11522656
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol induces apoptosis of human chronic myelogenous leukemia cells in vitro through p38 and JNK-regulated H2AX phosphorylation.
Wu XP; Xiong M; Xu CS; Duan LN; Dong YQ; Luo Y; Niu TH; Lu CR
Acta Pharmacol Sin; 2015 Mar; 36(3):353-61. PubMed ID: 25619392
[TBL] [Abstract][Full Text] [Related]
10. Anti-apoptotic effect of quercetin: intervention in the JNK- and ERK-mediated apoptotic pathways.
Ishikawa Y; Kitamura M
Kidney Int; 2000 Sep; 58(3):1078-87. PubMed ID: 10972672
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor alpha-induced E-selectin expression is activated by the nuclear factor-kappaB and c-JUN N-terminal kinase/p38 mitogen-activated protein kinase pathways.
Read MA; Whitley MZ; Gupta S; Pierce JW; Best J; Davis RJ; Collins T
J Biol Chem; 1997 Jan; 272(5):2753-61. PubMed ID: 9006914
[TBL] [Abstract][Full Text] [Related]
12. Arsenic trioxide induces apoptosis in chronic myelogenous leukemia K562 cells: possible involvement of p38 MAP kinase.
Shim MJ; Kim HJ; Yang SJ; Lee IS; Choi HI; Kim T
J Biochem Mol Biol; 2002 Jul; 35(4):377-83. PubMed ID: 12296996
[TBL] [Abstract][Full Text] [Related]
13. Retinoic acid inhibits induction of c-Jun protein by ultraviolet radiation that occurs subsequent to activation of mitogen-activated protein kinase pathways in human skin in vivo.
Fisher GJ; Talwar HS; Lin J; Lin P; McPhillips F; Wang Z; Li X; Wan Y; Kang S; Voorhees JJ
J Clin Invest; 1998 Mar; 101(6):1432-40. PubMed ID: 9502786
[TBL] [Abstract][Full Text] [Related]
14. Induction of apoptosis by shikonin through a ROS/JNK-mediated process in Bcr/Abl-positive chronic myelogenous leukemia (CML) cells.
Mao X; Yu CR; Li WH; Li WX
Cell Res; 2008 Aug; 18(8):879-88. PubMed ID: 18663379
[TBL] [Abstract][Full Text] [Related]
15. Early modifications in the expression of mitogen-activated protein kinase (MAPK/ERK), stress-activated kinases SAPK/JNK and p38, and their phosphorylated substrates following focal cerebral ischemia.
Ferrer I; Friguls B; Dalfó E; Planas AM
Acta Neuropathol; 2003 May; 105(5):425-37. PubMed ID: 12677442
[TBL] [Abstract][Full Text] [Related]
16. Suppression of ERK signaling evokes autocrine Fas-mediated death in arachidonic acid-treated human chronic myeloid leukemia K562 cells.
Chen KC; Liu WH; Chang LS
J Cell Physiol; 2010 Mar; 222(3):625-34. PubMed ID: 19927299
[TBL] [Abstract][Full Text] [Related]
17. The novel pyrrolo-1,5-benzoxazepine, PBOX-21, potentiates the apoptotic efficacy of STI571 (imatinib mesylate) in human chronic myeloid leukaemia cells.
Bright SA; Greene LM; Greene TF; Campiani G; Butini S; Brindisi M; Lawler M; Meegan MJ; Williams DC; Zisterer DM
Biochem Pharmacol; 2009 Feb; 77(3):310-21. PubMed ID: 19014913
[TBL] [Abstract][Full Text] [Related]
18. Novel pyrrolo-1,5-benzoxazepine compounds display significant activity against resistant chronic myeloid leukaemia cells in vitro, in ex vivo patient samples and in vivo.
Bright SA; McElligott AM; O'Connell JW; O'Connor L; Carroll P; Campiani G; Deininger MW; Conneally E; Lawler M; Williams DC; Zisterer DM
Br J Cancer; 2010 May; 102(10):1474-82. PubMed ID: 20407438
[TBL] [Abstract][Full Text] [Related]
19. The novel tubulin-targeting agent pyrrolo-1,5-benzoxazepine-15 induces apoptosis in poor prognostic subgroups of chronic lymphocytic leukemia.
McElligott AM; Maginn EN; Greene LM; McGuckin S; Hayat A; Browne PV; Butini S; Campiani G; Catherwood MA; Vandenberghe E; Williams DC; Zisterer DM; Lawler M
Cancer Res; 2009 Nov; 69(21):8366-75. PubMed ID: 19826055
[TBL] [Abstract][Full Text] [Related]
20. JNK1/c-Jun and p38 alpha MAPK/ATF-2 pathways are responsible for upregulation of Fas/FasL in human chronic myeloid leukemia K562 cells upon exposure to Taiwan cobra phospholipase A2.
Chen KC; Chiou YL; Chang LS
J Cell Biochem; 2009 Oct; 108(3):612-20. PubMed ID: 19670268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
